Healthcare · Pharmaceuticals & Biotechnology
No company profile on record yet.
| Fiscal year | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
|---|---|---|---|---|
| Total income (before exceptional items) | 839† | 706† | 581† | 470† |
| Net profit | 209 | 188 | 119 | 90 |
₹ Crore. † Summed from the four quarterly filings of that fiscal year.
Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.
| Name | Designation | Term end |
|---|---|---|
| Balasaheb Gulabrao Sawant | Executive Director | June 30, 2026 |
| Saloni Satish Wagh | Executive Director | June 30, 2026 |
| Satish Waman Wagh | Executive Director | June 30, 2026 |
| Shivani Satish Wagh | Executive Director | June 30, 2026 |
| Smita Satish Wagh | Executive Director | June 30, 2026 |
| Ganapati Dadasaheb Yadav | Independent Director | June 30, 2026 |
| Kothandaraman Hari | Independent Director | June 30, 2026 |
| Manish Ishwarlal Panchal | Independent Director | June 30, 2026 |
| Neelam Yashpal Arora | Independent Director | June 30, 2026 |
| Sunil Subhash Bhagwat | Independent Director | June 30, 2026 |
Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.
